# ExeVir Bio

**Private**  
**Belgium**  
**Healthcare & Life Sciences** [ExeVir Website](https://exevir.com/)

**Last Round**: Grant  
**Date**: Jun 28, 2023  
**Total Funding Raised**: $108.78M

## Company Overview

ExeVir Bio is a biotechnology company that develops single-domain antibody-based therapies for the treatment and prevention of infectious diseases.

**Sector**: Healthcare & Life Sciences  
**Verticals**: Biotechnology, Drug Discovery, Clinical Trials  
**Business Model**: B2B  
**Customer Profile**: Services & Consulting  
**AI Layer**: Non-AI  
**Keywords**: nanobody, vhh, antibody, antibody therapy, camelid antibody, biotech, drug discovery, monoclonal antibody, viral infection treatment, clinical-stage biotech, multispecific antibody, cdmo partnership, drug pipeline, llama-derived antibody

## Historical Pricing

Historical view of private secondary pricing and transaction trends.

### Unlock Pricing Charts

**Sign up to view complete historical pricing and secondary transactions.**

## Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

### View Momentum History

Track how buyer interest and sentiment changes over time.

## ExeVir Bio Comparables

Compare ExeVir Bio with similar companies based on industry and business-model similarity.

| Company | Similarity | Market Cap |
| --- | --- | --- |
| DiosCURE Therapeutics SE | 89% | Unlock |
| [Cerberus Therapeutics](/content/company/cerberustx/index.html) | 82% | Unlock |
| Invivyd | 79% | Unlock |
| Comparable company | 50% | Unlock |

## ExeVir Bio Funding Rounds

Historical fundraising activity.

| Round | Date | Amount Raised | Valuation | Investors | Sources |
| --- | --- | --- | --- | --- | --- |
| Grant | Jun 28, 2023 | Unlock | Unlock | Unlock | Unlock |
| Debt | Dec 14, 2022 | Unlock | Unlock | Unlock | Unlock |
| Grant | Jul 13, 2021 | Unlock | Unlock | Unlock | Unlock |
| Series A | Mar 16, 2021 | Unlock | Unlock | Unlock | Unlock |
| Series A | Jul 28, 2020 | Unlock | Unlock | Unlock | Unlock |

## Key People

### Founding team and executive leadership
- **Michael Garrett**  
  Chief Executive Officer  
  [LinkedIn profile](https://www.linkedin.com/in/michael-garrett-557b76a "LinkedIn profile")

- **Caroline Sagaert**  
  COO  
  [LinkedIn profile](https://www.linkedin.com/in/caroline-sagaert "LinkedIn profile")

## ExeVir Bio Investors

Notable investors and investment history.

| Investor | Rounds |
| --- | --- |
| [UCB Ventures](/content/investor/ucbventures/index.html) | Series A |
| [Federal Holding and Investment Company](/content/investor/sfpim-be/index.html) | Series A |
| [Sopartec](/content/investor/sopartec/index.html) | Series A |
| [Noshaq](/content/investor/noshaq-ventures/index.html) | Series A |
| [Fund+](/content/investor/fundplus/index.html) | Series A |
| [Société Régionale d'Investissement de Wallonie](/content/investor/sriw-be/index.html) | Series A |
| [UCB Ventures](/content/investor/ucb/index.html) | Series A |

## Market Signals

- **Jun 28, 2023**: $1.74M grant received from VLAIO.
- **Dec 14, 2022**: $27M round from European Investment Bank Group.

## ExeVir Bio Filings

SEC and related filings with document metadata.

| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
| --- | --- | --- | --- | --- | --- | --- |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |

## Frequently Asked Questions

- Is ExeVir Bio a public or private company?  
- What is the current stock price of ExeVir Bio?  
- How much is ExeVir Bio worth (valuation)?  
- Can I buy ExeVir Bio stock?  
- When was ExeVir Bio's last funding round?  
- Who are the main investors in ExeVir Bio?  
- Will ExeVir Bio IPO soon?  
- How can I track ExeVir Bio secondary market activity?

## Firmographic Details

- **Headquarters**: Belgium  
- **Employee Range**: 10  
- **Year Founded**: 2020  
- **Last Funding**: Jun 28, 2023